WEBULL

Can Appen’s Rising Dependence on China Offset U.S. AI Pressures for ASX:APX?

Simply Wall St · 11/02 01:25
  • Appen recently reported that while its China business delivered strong third-quarter earnings, ongoing challenges in the U.S. AI market weighed on performance, leaving quarterly revenue only marginally higher and EBITDA flat compared to the prior period.
  • This highlights the company's growing dependence on the Chinese AI sector, even as volatility in its core U.S. market presents risks to overall business stability.
  • We'll explore how ongoing U.S. market difficulties could reshape the outlook for Appen's future growth and diversification efforts.

Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Appen Investment Narrative Recap

To be a shareholder in Appen, you need to believe in the company’s ability to diversify beyond its traditional dependence on the U.S. AI market and generate reliable growth from new geographies like China. The latest results show China’s earnings making up for sluggish performance elsewhere, but not enough to materially shift the immediate catalyst: a turnaround or stabilization of demand from major U.S. clients, which remains the biggest near-term risk to the business.

Among recent updates, Appen’s reaffirmation of its 2025 earnings guidance, albeit at the lower end of its forecast range, stands out in light of the recent news. While this guidance signals management’s confidence in the company’s direction, ongoing volatility in key segments, especially in the U.S., could still affect Appen’s ability to meet growth targets if demand does not recover as anticipated.

However, investors should also be aware that, despite China’s growth, returns could structurally suffer if the business becomes too dependent on lower-margin markets...

Read the full narrative on Appen (it's free!)

Appen's narrative projects $299.3 million revenue and $3.9 million earnings by 2028. This requires 10.1% yearly revenue growth and a $25.4 million earnings increase from current earnings of -$21.5 million.

Uncover how Appen's forecasts yield a A$1.27 fair value, a 64% upside to its current price.

Exploring Other Perspectives

ASX:APX Community Fair Values as at Nov 2025
ASX:APX Community Fair Values as at Nov 2025

Nine individual fair value estimates from the Simply Wall St Community range from A$1.19 to A$4.47 per share, highlighting broad differences in expectations. Against this backdrop, the ongoing unpredictability in U.S. AI demand remains a pressing issue to consider as you review different viewpoints on Appen’s performance.

Explore 9 other fair value estimates on Appen - why the stock might be worth over 5x more than the current price!

Build Your Own Appen Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Appen research is our analysis highlighting 3 key rewards that could impact your investment decision.
  • Our free Appen research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Appen's overall financial health at a glance.

Contemplating Other Strategies?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.